125 related articles for article (PubMed ID: 2439199)
1. Nucleolar protein B23 translocation after doxorubicin treatment in murine tumor cells.
Chan PK; Aldrich MB; Yung BY
Cancer Res; 1987 Jul; 47(14):3798-801. PubMed ID: 2439199
[TBL] [Abstract][Full Text] [Related]
2. Short exposure to actinomycin D induces "reversible" translocation of protein B23 as well as "reversible" inhibition of cell growth and RNA synthesis in HeLa cells.
Yung BY; Bor AM; Chan PK
Cancer Res; 1990 Sep; 50(18):5987-91. PubMed ID: 1697505
[TBL] [Abstract][Full Text] [Related]
3. Cyclosporin A and verapamil enhancement of daunorubicin-produced nucleolar protein B23 translocation in daunorubicin-resistant and -sensitive human and murine tumor cells.
Sweet P; Chan PK; Slater LM
Cancer Res; 1989 Feb; 49(3):677-80. PubMed ID: 2910487
[TBL] [Abstract][Full Text] [Related]
4. Effects of luzopeptins on protein B23 translocation and ribosomal RNA synthesis in HeLa cells.
Yung BY; Busch H; Chan PK
Cancer Res; 1986 Feb; 46(2):922-5. PubMed ID: 3940652
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric screening for selective toxicity to multidrug-resistant cells.
Frankfurt OS
J Natl Cancer Inst; 1987 Oct; 79(4):831-6. PubMed ID: 3477663
[TBL] [Abstract][Full Text] [Related]
6. Effects of actinomycin D analogs on nucleolar phosphoprotein B23 (37,000 daltons/pI 5.1).
Yung BY; Busch RK; Busch H; Mauger AB; Chan PK
Biochem Pharmacol; 1985 Nov; 34(22):4059-63. PubMed ID: 2415133
[TBL] [Abstract][Full Text] [Related]
7. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
Lepri E; Menconi E; Barzi AM
Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1369-75. PubMed ID: 6477749
[TBL] [Abstract][Full Text] [Related]
8. [Difference in the distribution and content of nucleolar protein B23 between interphase and mitotic HeLa cells].
Yang X; Li S; Wang Y
Shi Yan Sheng Wu Xue Bao; 1994 Jun; 27(2):175-81. PubMed ID: 7976056
[TBL] [Abstract][Full Text] [Related]
9. Decreased retention of actinomycin D as the basis for cross-resistance in anthracycline-resistant sublines of P388 leukemia.
Inaba M; Johnson RK
Cancer Res; 1977 Dec; 37(12):4629-34. PubMed ID: 922743
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of acquired resistance to methotrexate in P388 murine leukemia cells and in their doxorubicin-resistant subline.
Ramu N; Ramu A; Cole DE; Balis FM; Poplack DG; Pollard HB
Isr J Med Sci; 1988; 24(9-10):477-82. PubMed ID: 2974448
[TBL] [Abstract][Full Text] [Related]
11. Effects of cytotoxic drugs on translocation of nucleolar RNA helicase RH-II/Gu.
Perlaky L; Valdez BC; Busch H
Exp Cell Res; 1997 Sep; 235(2):413-20. PubMed ID: 9299166
[TBL] [Abstract][Full Text] [Related]
12. Translocation of nucleolar phosphoprotein B23 (37 kDa/pI 5.1) induced by selective inhibitors of ribosome synthesis.
Yung BY; Busch H; Chan PK
Biochim Biophys Acta; 1985 Dec; 826(4):167-73. PubMed ID: 3907710
[TBL] [Abstract][Full Text] [Related]
13. Studies of actinomycin D induced B23-translocation in P388D1 cells implanted in DBA/2 mice.
Finch RA; Chan PK
Oncology; 1992; 49(3):223-6. PubMed ID: 1495750
[TBL] [Abstract][Full Text] [Related]
14. Differences in daunomycin retention in sensitive and resistant P388 leukemic cells as determined by digitized video fluorescence microscopy.
Yanovich S; Taub RN
Cancer Res; 1983 Sep; 43(9):4167-71. PubMed ID: 6871858
[TBL] [Abstract][Full Text] [Related]
15. Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells.
Ramu A; Glaubiger D; Magrath IT; Joshi A
Cancer Res; 1983 Nov; 43(11):5533-7. PubMed ID: 6311408
[TBL] [Abstract][Full Text] [Related]
16. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
[TBL] [Abstract][Full Text] [Related]
17. Alterations in immunolocalization of the phosphoprotein B23 in HeLa cells during serum starvation.
Chan PK; Aldrich M; Busch H
Exp Cell Res; 1985 Nov; 161(1):101-10. PubMed ID: 2414117
[TBL] [Abstract][Full Text] [Related]
18. Altered subcellular distribution of nucleolar protein fibrillarin by actinomycin D in HEp-2 cells.
Chen M; Jiang P
Acta Pharmacol Sin; 2004 Jul; 25(7):902-6. PubMed ID: 15210063
[TBL] [Abstract][Full Text] [Related]
19. Potentiation of actinomycin D or adriamycin antitumor activity with DNA.
Marks TA; Venditti JM
Cancer Res; 1976 Feb; 36(2 Pt 1):496-504. PubMed ID: 1260747
[TBL] [Abstract][Full Text] [Related]
20. A fluorine-containing anthracycline (ME2303) as a new antitumor agent against murine and human tumors and their multidrug-resistant sublines.
Tsuruo T; Yusa K; Sudo Y; Takamori R; Sugimoto Y
Cancer Res; 1989 Oct; 49(20):5537-42. PubMed ID: 2790778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
